Skip to main content
. 2010 Apr;51(4):755–762. doi: 10.1194/jlr.M001487

TABLE 2.

Associations between noncholesterol sterols and LDL-C change

Simvastatin 80 mg (N = 289)
Ezetimibe/Simvastatin 10/80 mg (N = 302)
Baseline Noncholesterol Sterols β P β P
Campesterol (mg/dl) −0.072 0.166 0.009 0.825
Sitosterol (mg/dl) −0.020 0.705 −0.010 0.806
Lathosterol (mg/dl) −0.001 0.981 0.057 0.148
Campesterol/TC (μg/mg) −0.051 0.287 0.020 0.587
Sitosterol/TC (μg/mg) 0.008 0.871 <0.001 0.992
Lathosterol/TC (μg/mg) 0.005 0.927 0.053 0.154
Change in Sterols Simvastatin 80 mg (N = 289) Ezetimibe/Simvastatin 10/80 mg (N = 302)
Δ Campesterol 2y (mg/dl) 0.235 <0.001 0.081 0.047
Δ Sitosterol 2y (mg/dl) 0.206 <0.001 0.125 0.003
Δ Lathosterol 2y (mg/dl) 0.232 <0.001 0.157 <0.001
Δ Campesterol/TC 2y (μg/ml) −0.180 <0.001 −0.013 0.736
Δ Sitosterol/TC 2y (μg/ml) −0.193 <0.001 −0.021 0.570
Δ Lathosterol/TC 2y (μg/ml) 0.135 0.001 0.083 0.026

Data were analyzed in a multiple regression model with LDL-C change from baseline as dependent variable and the noncholesterol sterol and baseline LDL-C as independent variables. In addition, associations between change in absolute noncholesterol sterol levels and LDL-C change were analyzed. In this model, LDL change from baseline served as dependent variable and change in the noncholesterol sterol and baseline LDL-C as independent variables. β represents the standardized β coefficient.